Antimicrobial resistance (AMR) is on the rise and poses a significant threat to global health, with the risk of modern medicines becoming ineffective. There is an extensive need for new antimicrobials to treat both bacterial and fungal infections.

The Antimicrobial Screening Facility at the University of Warwick is primed to support AMR research and aid in the discovery of new antibiotic and antifungal treatments. It is equipped with state-of-the-art equipment and a wealth of knowledge from expert academics in the drug discovery field.

Providing a wide range of testing, spanning from rapid antimicrobial susceptibility investigations to comprehensive studies into the way antimicrobials work (mode-of-action studies), we offer an efficient and cost-effective service for external clients from industry and academia.

We can help you with:

• Antimicrobial susceptibility testing against biosafety level 1 and 2 pathogens.
• Investigations into evolving antimicrobial resistance and frequency of spontaneous mutation.
• Synergy experiments (assessing how antimicrobials interact).
• Cytotoxicity testing (assessing the toxicity of compounds or materials).
• Anti biofilm experiments (studying the effectiveness of antimicrobials targeting bacteria that form thin films, a key defence mechanism).
• Antimicrobial surface testing.

Find out more

To discuss your requirements in more detail and find out how we can help provide a solution to your challenge, contact Dr Jenny Littler ( ), Senior Scientist in the Antimicrobial Screening Facility or Claire Gerard ( ), Warwick Scientific Services Manager.

About AMR research at Warwick

The University of Warwick has a wealth of expertise in AMR research which underpins the services provided by the Antimicrobial Screening Facility.

The University’s Sir Howard Dalton Centre is a network of academics driving research into AMR. It has recently received a £1.5 million donation from The Great Britain Sasakawa Foundation, which will facilitate collaborative research into AMR between the UK and Japan.